Is There a Role for the Therapeutic Drug Monitoring of Colistin? An Overview

Colistin is used as a last-line antibiotic for the treatment of Gram-negative multiresistant bacteria. Due to its high nephrotoxicity, Therapeutic Drug Monitoring (TDM) is recommended for dose adjustment. We aimed to evaluate the available evidence of TDM in patients given colistin to treat Gram-neg...

Full description

Saved in:
Bibliographic Details
Main Authors: Maria-Paula Avila (Author), Tatiana Pacheco (Author), Sara Arias (Author), Rosa-Helena Bustos (Author), Julio-Cesar Garcia (Author), Diego Jaimes (Author)
Format: Book
Published: MDPI AG, 2020-03-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_da4ce9a20c6e49b6964cbd0b8be698f4
042 |a dc 
100 1 0 |a Maria-Paula Avila  |e author 
700 1 0 |a Tatiana Pacheco  |e author 
700 1 0 |a Sara Arias  |e author 
700 1 0 |a Rosa-Helena Bustos  |e author 
700 1 0 |a Julio-Cesar Garcia  |e author 
700 1 0 |a Diego Jaimes  |e author 
245 0 0 |a Is There a Role for the Therapeutic Drug Monitoring of Colistin? An Overview 
260 |b MDPI AG,   |c 2020-03-01T00:00:00Z. 
500 |a 1424-8247 
500 |a 10.3390/ph13030042 
520 |a Colistin is used as a last-line antibiotic for the treatment of Gram-negative multiresistant bacteria. Due to its high nephrotoxicity, Therapeutic Drug Monitoring (TDM) is recommended for dose adjustment. We aimed to evaluate the available evidence of TDM in patients given colistin to treat Gram-negative infections. In this paper, we offer an overview, using an electronic search of the literature (published up to June 2019, without language restrictions) that compares the clinical outcomes and measurements of colistin TDM. Ultimately, the Therapeutic Drug Monitoring (TDM) of colistin in Plasma could prevent nephrotoxicity risk. 
546 |a EN 
690 |a therapeutic drug monitoring (tdm) 
690 |a colistin 
690 |a multiresistant bacteria 
690 |a Medicine 
690 |a R 
690 |a Pharmacy and materia medica 
690 |a RS1-441 
655 7 |a article  |2 local 
786 0 |n Pharmaceuticals, Vol 13, Iss 3, p 42 (2020) 
787 0 |n https://www.mdpi.com/1424-8247/13/3/42 
787 0 |n https://doaj.org/toc/1424-8247 
856 4 1 |u https://doaj.org/article/da4ce9a20c6e49b6964cbd0b8be698f4  |z Connect to this object online.